
|Articles|August 15, 2004
Mast cell stabilizers control ocular itching to cat allergen
Fort Lauderdale, FL-Two pilot studies have shown that single doses of olopatadine HCl ophthalmic solution 0.1% (Patanol, Alcon Laboratories) and pemirolast potassium ophthalmic solution 0.1% (Alamast, Santen Inc./Johnson and Johnson) were comparable in reducing and controlling ocular itching in cat-sensitive individuals, according to Jason S. Rothman, MD, Cornea fellow, New England Eye Center, Tufts University School of Medicine, Boston.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
2
First patient treated in ViaLase’s IDE trial
3
PainReform launches development plan for OcuRing-K, readies phase 2 trial
4
Avisi Technologies treats first patient in SAPPHIRE trial for glaucoma
5















































.png)


